Cyclophosphamide (CP), a prodrug that is enzymatically converted to the cytotoxic 4-hydroxycyclophosphamide (4OHCP) by hepatic enzymes, is commonly used in both human and veterinary medicine to treat cancers and modulate the immune system. We investigated the metabolism of CP in humans, dogs, cats, and mice using liver microsomes; apparent , , and intrinsic clearance ( / ) parameters were estimated. The interspecies and intraspecies variations in kinetics were vast.
View Article and Find Full Text PDF